Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine in HBeAg positive chronic hepatitis B pregnant women
NCT01337791Phase 4Completed
- Sponsor
- Southeast University
- Start
- Aug 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Southeast University. Started Aug 2008; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01337791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337791.